BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10547428)

  • 1. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
    Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
    Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
    Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
    J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization.
    Iwasaki A; Dela Cruz CS; Young AR; Barber BH
    Vaccine; 1999 Apr; 17(15-16):2081-8. PubMed ID: 10217610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.
    Fu TM; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    J Virol; 1997 Apr; 71(4):2715-21. PubMed ID: 9060624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
    Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
    Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.
    Chen Z; Yoshikawa T; Kadowaki SE; Hagiwara Y; Matsuo K; Asanuma H; Aizawa C; Kurata T; Tamura SI
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2559-2564. PubMed ID: 10573147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.
    Kodihalli S; Kobasa DL; Webster RG
    Vaccine; 2000 May; 18(23):2592-9. PubMed ID: 10775793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination.
    Chen Y; Webster RG; Woodland DL
    J Immunol; 1998 Mar; 160(5):2425-32. PubMed ID: 9498786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
    Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
    Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
    Berkhoff EGM; Geelhoed-Mieras MM; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2007 Feb; 88(Pt 2):530-535. PubMed ID: 17251571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein.
    Bot A; Bot S; Bona C
    Vaccine; 1998 Oct; 16(17):1675-82. PubMed ID: 9713946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
    Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
    Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
    Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL
    Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.
    Tourdot S; Oukka M; Manuguerra JC; Magafa V; Vergnon I; Riché N; Bruley-Rosset M; Cordopatis P; Kosmatopoulos K
    J Immunol; 1997 Sep; 159(5):2391-8. PubMed ID: 9278330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
    Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
    Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor.
    Iwasaki A; Barber BH
    Cancer Immunol Immunother; 1998 Jan; 45(5):273-9. PubMed ID: 9439651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.